First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study

BACKGROUND: This phase II study evaluated the efficacy and safety of gemcitabine (G) plus paclitaxel (T) as first-line therapy in recurrent or metastatic breast cancer. METHODS: Patients with locally, recurrent or metastatic breast cancer and no prior chemotherapy for metastatic disease received G 1...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Allouache, Djelila, Gawande, Sulochana R, Tubiana-Hulin, Michele, Tubiana-Mathieu, Nicole, Piperno-Neumann, Sophie, Mefti, Fawzia, Bozec, Laurence, Genot, Jean-Yves
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2005
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC1315334/
https://ncbi.nlm.nih.gov/pubmed/16316459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-5-151
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы